Showing results (41-50 of 58) with videos related to

Sort By:
Pageof 6
International Journal of Molecular Sciences|December 23, 2023
Tonabersat Significantly Reduces Disease Progression in an Experimental Mouse Model of Multiple SclerosisAndrea Kwakowsky, Bhavya Chawdhary, Antonio de Souza, et al.
Plos One|February 15, 2018
A comprehensive meta-analysis of circulation miRNAs in glioma as potential diagnostic biomarkerChenkai Ma, Hong P T Nguyen, Rodney B Luwor, et al.
Cancer Biology & Therapy|February 22, 2014
Anti-EGFR therapeutic efficacy correlates directly with inhibition of STAT3 activityNelson Ung, Tracy L Putoczki, Stanley S Stylli, et al.
Translational Oncology|September 17, 2018
Inhibition of Radiation and Temozolomide-Induced Invadopodia Activity in Glioma Cells Using FDA-Approved DrugsClarissa A Whitehead, Hong P T Nguyen, Andrew P Morokoff, et al.
Cells|November 6, 2019
Therapeutic Targeting of Cancer Stem Cells in Human Glioblastoma by Manipulating the Renin-Angiotensin SystemDavid Ch Tan, Imogen M Roth, Agadha C Wickremesekera, et al.
Frontiers in Bioscience (Landmark Edition)|September 30, 2021
The renin-angiotensin system in central nervous system tumors and degenerative diseasesSimon Haron, Ethan J Kilmister, Paul F Davis, et al.
Journal of Clinical Neuroscience : Official Journal of the Neurosurgical Society of Australasia|March 29, 2021
Temporal patterns of visual recovery following pituitary tumor resection: A prospective cohort studyMichael T M Wang, James King, R C Andrew Symons, et al.
Molecular and Cellular Biochemistry|October 27, 2022
Repurposing FDA-approved drugs as inhibitors of therapy-induced invadopodia activity in glioblastoma cellsDylan Jones, Clarissa A Whitehead, Marija Dinevska, et al.
Oncotarget|June 6, 2015
The peroxisome proliferator activated receptor gamma agonist pioglitazone increases functional expression of the glutamate transporter excitatory amino acid transporter 2 (EAAT2) in human glioblastoma cellsJared Ching, Stephanie Amiridis, Stanley S Stylli, et al.
Cancers|December 22, 2018
Ponatinib Inhibits Multiple Signaling Pathways Involved in STAT3 Signaling and Attenuates Colorectal Tumor GrowthFiona H Tan, Tracy L Putoczki, Jieqiong Lou, et al.
Pageof 6